Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Prediction of hepatocellular carcinoma (HCC) risk becomes increasingly important with recently emerging HCC-predisposing conditions, namely non-alcoholic fatty liver disease and cured hepatitis C virus infection. These etiologies are accompanied with a relatively low HCC incidence rate (~1% per year...
Main Authors: | Naoto Kubota, Naoto Fujiwara, Yujin Hoshida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/3843 |
Similar Items
-
A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
by: Hao-dan Mao, et al.
Published: (2023-03-01) -
Establishment and Clinical Application of the Nomogram Related to Risk or Prognosis of Hepatocellular Carcinoma: A Review
by: Wang X, et al.
Published: (2023-08-01) -
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01) -
Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study
by: Ji Hyun Kim, et al.
Published: (2020-11-01) -
Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
by: Ke Shi, et al.
Published: (2023-02-01)